Literature DB >> 1711513

Distribution and localization of inter-alpha-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohistochemical study.

E Yoshida1, H Sumi, H Tsushima, M Maruyama, H Mihara.   

Abstract

Inter-alpha-trypsin inhibitor (ITI) is a complex that consists of three components. One of these is the acid-stable proteinase inhibitor (ASPI), which is an acute-phase reactant and a broad-spectrum inhibitor. The tissue distribution of ITI and ASPI were investigated and compared using immunohistochemical methods. ITI immunoreactivity was revealed only in the liver and plasma, while ASPI immunoreactivity was found to be distributed in the brain, liver, kidney, gastrointestinal tract, plasma, and urine. Both immunoreactivities were demonstrated in Kupffer cells of the liver, which is thought to be an ITI-producing organ. From these results, it seems unlikely that ASPI is distributed as a part of the ITI molecule. The residual component of ITI may act as a carrier protein of ASPI, or ASPI in the tissues may be produced independently of ITI.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711513     DOI: 10.1007/bf00917911

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

1.  The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC).

Authors:  J F Kaumeyer; J O Polazzi; M P Kotick
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

2.  Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI.

Authors:  J P Salier; M Diarra-Mehrpour; R Sesboue; J Bourguignon; R Benarous; I Ohkubo; S Kurachi; K Kurachi; J P Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Analysis of inter-alpha-trypsin inhibitor and a novel trypsin inhibitor, pre-alpha-trypsin inhibitor, from human plasma. Polypeptide chain stoichiometry and assembly by glycan.

Authors:  J J Enghild; I B Thøgersen; S V Pizzo; G Salvesen
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

4.  Development and application of an enzyme-linked immunosorbent assay for acid stable trypsin inhibitor (ASTI) in human plasma.

Authors:  E Yoshida; H Sumi; M Maruyama; H Mihara; R Sakai
Journal:  Clin Chim Acta       Date:  1987-08-14       Impact factor: 3.786

5.  Serum levels of a component reacting with antiserum to urinary antitrypsin in health and disease with emphasis on high levels in renal failure.

Authors:  J M Smith; M B Balabanian; R M Freeman
Journal:  J Lab Clin Med       Date:  1976-12

6.  A proteoglycan related to the urinary trypsin inhibitor (UTI) links the two heavy chains of inter-alpha-trypsin inhibitor.

Authors:  M Balduyck; S Laroui; C Mizon; J Mizon
Journal:  Biol Chem Hoppe Seyler       Date:  1989-04

7.  cDNA cloning of human inter-alpha-trypsin inhibitor discloses three different proteins.

Authors:  T Schreitmüller; K Hochstrasser; P W Reisinger; E Wachter; W Gebhard
Journal:  Biol Chem Hoppe Seyler       Date:  1987-08

8.  Urinary trypsin inhibitory capacity determination: study in patients with disseminated cancers.

Authors:  C Mizon; M Balduyck; J P Bonneterre; J Mizon
Journal:  Bull Cancer       Date:  1983       Impact factor: 1.276

9.  Isolation and characterization of an inter-alpha-trypsin inhibitor-IgG complex from human serum.

Authors:  J P Salier; R Sesboüé; K Hochstrasser; O Schönberger; J P Martin
Journal:  Biochim Biophys Acta       Date:  1983-01-12

10.  Human inter-alpha-trypsin inhibitor and immunologically related inhibitors investigated by quantitative immunoelectrophoresis. II. Pathological conditions.

Authors:  L Odum; G Hansen-Nord; I Byrjalsen
Journal:  Clin Chim Acta       Date:  1987-01-30       Impact factor: 3.786

View more
  6 in total

Review 1.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

2.  Expression and localization of Inter-alpha Inhibitors in rodent brain.

Authors:  X Chen; L Rivard; S Naqvi; S Nakada; J F Padbury; J Sanchez-Esteban; E G Stopa; Y-P Lim; B S Stonestreet
Journal:  Neuroscience       Date:  2016-03-08       Impact factor: 3.590

3.  Effects of inter-alpha inhibitor proteins on neonatal brain injury: Age, task and treatment dependent neurobehavioral outcomes.

Authors:  Steven W Threlkeld; Cynthia M Gaudet; Molly E La Rue; Ethan Dugas; Courtney A Hill; Yow-Pin Lim; Barbara S Stonestreet
Journal:  Exp Neurol       Date:  2014-07-30       Impact factor: 5.330

4.  Immunohistochemical demonstration of bikunin, a light chain of inter-alpha-trypsin inhibitor, in human brain tumors.

Authors:  E Yoshida; M Maruyama; M Sugiki; H Mihara
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

5.  Laser capture microdissection and genetic analysis of carbon-labeled Kupffer cells.

Authors:  Stephan Gehring; Edmond Sabo; Maryann E San Martin; Elizabeth M Dickson; Chao-Wen Cheng; Stephen H Gregory
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

6.  Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine.

Authors:  F Atmani; S R Khan
Journal:  Urol Res       Date:  1995
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.